(Q51050741)

English

Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

author name string

O Haigh

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

J Kattenbelt

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

M Cochrane

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

S Thomson

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

A Gould

5

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

R Tindle

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

publication date

11 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

17

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

10

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

708-720

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

https://scigraph.springernature.com/pub.10.1038/cgt.2010.27

0 references

p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

The coming of age of tumour immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Progress in human tumour immunology and immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Alternative processing of endogenous or exogenous antigens extends the immunogenic, H-2 class I-restricted peptide repertoire

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Role of transfection in the priming of cytotoxic T-cells by DNA-mediated immunization

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

DNA vaccines: precision tools for activating effective immunity against cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

The causal relation between human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Prevention of cervical cancer through papillomavirus vaccination

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Immune evasion in human papillomavirus-associated cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Vaccination for treatment and prevention of cancer in animal models.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Improved immunogenicity of HIV-1 epitopes in HBsAg chimeric DNA vaccine plasmids by structural mutations of HBsAg

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Novel pathways of antigen presentation for the maintenance of memory.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

The role of the downstream signal sequences in the maturation of the HBV middle surface glycoprotein: development of a novel therapeutic vaccine candidate

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

The original sin of killer T cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

CD8+ T cell efficacy in vaccination and disease

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

21 January 2018

Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

The lymphatic spread of carcinoma of the cervix and of the body of the uterus; a study of 420 necropsies

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary immunisation with high-dose heterologous peptide leads to CD8 T cell populations with reduced functional avidity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CGT.2010.27

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/20539319

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51050741&oldid=1455609467"